- For Print
- April 28, 2021
Saitama Resona Bank, Limited
Eisai Co., Ltd.
Saitama Resona Bank, Limited (Headquarters: Saitama, President: Satoshi Fukuoka, “Resona”), a corporation of the Resona Group, and Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that both parties have entered into a business alliance agreement for building an ecosystem with the aim of supporting people living with and preventing dementia (“dementia ecosystem”), in order to realize a regional community where citizens of Saitama Prefecture can live with peace of mind for a long time while maintaining their health.
In Saitama Prefecture, the speed of aging of society is estimated to be at the top level in Japan. Therefore, one of the major issues is making efforts to create a community where people can live with dementia, and prevent the onset of dementia. Through this business alliance, Resona and Eisai will build a “dementia ecosystem” that combines Resona’s customer network in Saitama Prefecture and Eisai’s wealth of experience and knowledge in drug creation activities and disease awareness activities in the field of dementia, aiming to support Saitama citizens and people working in companies in Saitama prefecture to maintain a healthy life and create a sustainable community.
As the first step in this effort, the customers of the investment trust “SAITAMA RESONA GLOBAL BALANCE PLUS ESG ~ SaitamaDGs ~”*1 handled by Resona will be provided with Eisai’s digital tool for self-assessment of brain performance (brain health) “NouKNOWTM” (pronounced “NOH-NOH”, non-medical device).*2 We will provide the customers at Resona with opportunities to build assets and contribute to the local community through investment in Saitama Prefecture bonds, etc., and support them to secure their life by providing an opportunity to regularly check brain performance and maintain brain health by improving lifestyle habits.
Furthermore, Resona and Eisai will collaborate with local governments, companies, universities, public institutions, etc. in Saitama Prefecture through the dementia ecosystem, aiming to co-create value for realizing a sustainable community where citizens of the prefecture can live with peace of mind. For example, to reduce and eliminate anxieties, to enable them to lead a prosperous retirement life, or to enable companies in Saitama Prefecture to engage in efforts for health and productivity management.
【Image of a sustainable community with dementia ecosystem】
*1 This is an investment trust in which Resona makes international diversified investments and ESG investments as a medium- to long-term asset formation support for its customer, as well as investments in Saitama prefectural bonds. Resona provides its customers with the opportunity to participate in the realization of the SDGs and contribute to the local community and society in Saitama Prefecture through their asset management. Resona will meet the needs of its customers who want to contribute to the creation of a society that can withstand the COVID-19 pandemic, by donating a part of the profits of the product to Saitama Prefecture’s “COVID-19 Infection Countermeasure Fund” which is the initiative taken by the Saitama Prefecture Office to support the activities of medical professionals and medical institutions.
*2 “NouKNOW” is conducted through a simple card test using a PC or tablet device to quantitatively measure brain performance in four tests evaluating psychomotor function, attention, learning and memory, and working memory. This digital tool allows users to self-assess independently and in a short time frame (approx.15 minutes), enabling regular assessments in instances such as daily life and health checkups. On the results screen, a score (brain performance index (BPI)) - as a measurement of quantified brain performance aspects such as memorization, cognition, and decision - appears along with lifestyle advice for maintaining brain performance.
Resona Holdings, Inc.
Corporate Communications Division,
TEL: +81- (0)48 835-1524
Eisai Co., Ltd.
Public Relations Department
<Notes to editors>
1. About Saitama Resona Bank, Limited
Since its founding, Saitama Resona Bank has remained the same as it is aiming to be, “a bank that is trusted by the people of Saitama Prefecture and develops together with the locality of Saitama.” To achieve this, Saitama Resona Bank is united in the challenge of demonstrating its unique value in being a close and reliable partner for the future of the community and customers’ lives and businesses.
The Resona Group, including Saitama Resona Bank, announced a new medium-term management plan in May 2020. Based on the fundamental policy of “establishing a resonance model” aiming at the sustainable growth of society and the group, we will offer new value to our customers through various “Resonance” that fosters new ideas and a wide range of connections, without being bound by the conventional wisdom and framework of banks, starting from our efforts to address the problems for customers and the social issues.
Furthermore, we intend to deepen cooperation with Saitama Prefecture Office and each municipality, company, school, etc. in the prefecture, and to actively participate in diverse fields, including next-generation urban development, environment, culture, and education. Thus, we will take on the challenge of providing new and valuable services without being bound by the financial framework, and will work to revitalize the local economy and solve regional issues.
For further information on Saitama Resona Bank, Limited, please visit https://www.saitamaresona.co.jp/ (in Japanese only)
2．About Eisai Co., Ltd.
Eisai Co., Ltd. is a leading global research and development-based pharmaceutical company headquartered in Japan. We define our corporate mission as “giving first thought to patients and their families and to increasing the benefits health care provides,” which we call our human health care (hhc) philosophy. With approximately 10,000 employees working across our global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to realize our hhc philosophy by delivering innovative products to address unmet medical needs, with a particular focus in our strategic areas of Neurology and Oncology.
Eisai has started a new medium-term business plan “EWAY Future & Beyond” in April 2021, aiming to remove the anxiety of The People, including not only patients but also individual consumers, with delivering not only pharmaceutical products but also solutions to The People, utilizing the latest digital technology such as AI. Eisai will achieve this goal with “hhceco”, which is the hhc philosophy combined with ecosystem. Eisai aims to remove diverse anxiety of The People by coexisting with various industries and associations, centered on the Eisai Universal Platform which delivers a packaged solutions in addition to pharmaceutical products through synergies between the technologies of various external partners and its own R&D.
As a global pharmaceutical company, our mission extends to patients around the world through our investment and participation in partnership-based initiatives to improve access to medicines in developing and emerging countries.
For more information about Eisai Co., Ltd., please visit https://www.eisai.com